MISSION Therapeutics
Biotechnology company developing therapies that enhance mitophagy (removal of dysfunctional mitochondria) to combat serious diseases including neurodegeneration and cancer.
Location
Cambridge, United Kingdom
Founded
2011
Investors
1
Categories
biotech, mitochondria, therapeutics, neurodegeneration, dub-inhibitors
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |
